期刊文献+

急性心肌梗死患者1个月内预后的临床相关因素分析 被引量:3

Analysis on Clinical Related Factors of the Prognosis of Acute Myocardial Infarction Within aMonth
下载PDF
导出
摘要 【目的】明确影响急性心肌梗死预后的独立危险因素。【方法】纳入2006年6月到2011年6月期间在广元市中心医院出院和死亡病历中诊断为急性心肌梗死的408例患者的病历资料,设计调查量表及资料提取表格。根据资料中急性心肌梗死患者发病后1个月内的死亡情况,将患者资料分为已死亡患者组和未死亡患者组进行对比分析,明确年龄、血压、血脂等是否为影响急性心肌梗死预后的独立危险因素。【结果】年龄增加、血压升高、血糖增加、血脂升高、曾有脑卒中事件可增加急性心肌梗死患者的病死率,而心肌酶及血红蛋白含量降低也有同等效应。【结论】通过回归分析可知,血压、年龄、甘油三脂、胆固醇、吸烟是影响急性心肌梗死患者入院后1个月内死亡的重要独立预测因素,其中年龄因素最为重要。 [Objective] To clarify the independent risk factors affecting the prognosis of acute myocardial infarction. [Methods] Case records of 408 patients diagnosed as acute myocardial infarction in central hospital of Guangyuan city from June 2006 to June 2011 were enrolled in the study. Investigation scale and data extraction table were designed. According to the death status of acute myocardial infarction within a month after disease onset, the documents of patients were divid- ed into dead patient group and non-dead patient group, and compared between tow groups. The independent risk factors such as age, blood pressure and blood lipids influencing the prognosis of acute myocardial infarction were clarified. IRe- sults] The increasing of age, blood pressure, blood glucose and blood lipids and the history of stroke events could increase the mortality of patients with acute myocardial infarction, and the decreasing of cardiac enzymes and hemoglobin level also had the equal effect. [Conclusion]Regression analysis shows that blood pressure, age, triglyeeride, cholesterol and smok- ing are the vital independent predictors affecting the death of patients with acute myocardial infarction within a month, and age is the most important.
出处 《医学临床研究》 CAS 2012年第8期1461-1463,共3页 Journal of Clinical Research
关键词 心肌梗塞 急性病 预后 Myocardial infarction~ acute disease ~ prognosis
  • 相关文献

参考文献6

  • 1Herlitz J, McGovern P, Dellborg M,et al . Comparison of treatment and outcomes for patients with acute myocardial infarction in Minneapolis/St. Paul, Minnesota? and Goteborg, Sweden[J]. Am Heart J ,2003, 146(6) : 1023-1029.
  • 2Mehta RH, Rathore SS, Radford MJ, et al . Acute myocardialinfarction in the elderiy- differences by age[J]. J Am Coll Cardiol ,2001, 38(3):736-741.
  • 3Gurwitz JH, Goldberg RJ, Malmgren JA, et al , Hospital transfer of patients with acute myocardial infarction : the effects of age, race, and insurance type [ J]. Am J Med, 2002, 112(7):528-534.
  • 4Van de Werf F,Ardissino D,Betriu h, et al . Management ofacute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Aogy[J]. Eur Heart J ,2003, 24(1):28-66.
  • 5Tresch DD, Berkompas D. Management of acute myocardial infarction in the elderly[J]. Cleve Clin J Med ,1995, 62(3):156-162.
  • 6梁金锐,沈潞华,于俊民,朴圣淑.急性心肌梗塞患者血脂水平分析[J].中华心血管病杂志,1999,27(4):280-282. 被引量:11

二级参考文献4

  • 1庄汉忠 韩琴琴 等.城乡健康人血清胆固醇、甘油三酯和β脂蛋白含量的研究[J].中华心血管病杂志,1983,11:265-268.
  • 2崔启文 安银东 等.血清总胆因醇含量正常的急性心肌梗塞患者血清高密度脂蛋白胆固醇含量[J].中华心血管病杂志,1984,12:199-200.
  • 3崔启文,中华心血管病杂志,1984年,12卷,199页
  • 4庄汉忠,中华心血管病杂志,1983年,11卷,265页

共引文献10

同被引文献39

  • 1王永进,王泽惠,侯云生,王天轶.门冬氨酸钾镁治疗急性心肌梗死的临床研究[J].中国急救医学,2004,24(10):736-737. 被引量:3
  • 2潘南金临床试验协作组,张福奎.门冬氨酸钾镁治疗肝功能异常的临床研究[J].医学临床研究,2004,21(11):1271-1274. 被引量:6
  • 3杨浩军,杜万红,刘小阳,李红英,张勇,陈宏.老年人动态心电图心律失常特征分析[J].医学临床研究,2007,24(1):82-84. 被引量:18
  • 4王保富.北京某部公安监管干警心血管危险因素分析[J].中国医师杂志,2012,(z1):66-67.
  • 5Tognon G, Berg C, Mehlig K, et al. Comparison of apolipoprotein (apoB/apoA-I) and lipoprotein (total cholesterol/HDL) ratio determinants. Focus onobesity, diet and alcohol intake[J]. PLoS One, 2012,7(7):e40878.
  • 6Zhang B, Kawachi E, Matsunaga A, et al. Reactivity of direct assays for low-density lipoprotein (LDL) cholesterol toward charge-modified LDL inhypercholesterolemia[J]. Circ J, 2012,76(9):2241-2248.
  • 7Baker JV, Neuhaus J, Duprez D, et al. Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation ofantiretroviral therapy[J]. AIDS, 2011,25(17):2133-2142.
  • 8Hamoud S, Kaplan M, Meilin E, et al. Niacin administration significantly reduces oxidative stress in patients with hypercholesterolemia and low levelsof high-density lipoprotein cholesterol[J]. Am J Med Sci, 2013,345(3):195-199.
  • 9Farnier M, Ducobu J, Bryniarski L. Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixedhyperlipidemia not controlled by pravastatin monotherapy[J]. Curr Med Res Opin, 2011,27(11):2165-2173.
  • 10Ballantyne CM, Pitt B, Loscalzo J, et al. Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy inpatients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin[LUNAR] Trial)[J]. Am J Cardiol, 2013,111(4):506-509.

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部